ArticleInternational urogynecology journal2026
Alpha-Linolenic Acid and Tarantula Cubensis Extract Attenuate Bladder Inflammation in Cyclophosphamide-Induced Cystitis: A Comparative Experimental Study.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introduction and hypothesisPrimary bladder pain syndrome (PBPS) is a chronic inflammatory bladder disorder characterized by pelvic pain, urinary urgency, and frequency. Current intravesical therapies such as hyaluronic acid (HA) mainly restore the urothelial barrier but may not adequately address inflammatory and oxidative mechanisms underlying bladder injury. We investigated whether alpha-linolenic acid (ALA) and Tarantula cubensis extract (TCAE) provide greater protection than intravesical HA in an experimental cystitis model.
methodsForty female Wistar rats were randomly assigned to five groups: control, cyclophosphamide (CYP)-induced cystitis, CYP + HA, CYP + TCAE, and CYP + ALA. Chemical cystitis was induced with intraperitoneal CYP (75 mg/kg). HA was administered intravesically, TCAE intraperitoneally, and ALA orally. Bladder tissues were evaluated using histopathological scoring and biochemical analyses measuring IL-6, TNF-α, SOD1, malondialdehyde [MDA]), and nerve growth factor-β (NGF-β).
resultsCYP administration produced marked bladder injury characterized by epithelial degeneration, submucosal edema, inflammatory infiltration, fibrosis, and increased mast cell density. Both ALA and TCAE improved these histopathological alterations compared with untreated cystitis. The greatest recovery was observed in the ALA group. Tissue MDA levels differed significantly among groups, with the lowest values observed in the ALA group. In contrast, IL-6, TNF-α, SOD1, and NGF-β levels showed group-related trends but did not reach statistical significance.
conclusionsALA and TCAE attenuated bladder injury in this experimental cystitis model, with ALA demonstrating the most pronounced histological and antioxidative effects. These findings support further investigation of ALA as a potential therapeutic strategy in experimental bladder inflammation.
Indexed as
Identifiers
42776190What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.